Citations 2
Clinical evaluation of germline polymorphisms (SNPs) associated with capecitabine (C) toxicity (tox) in metastatic breast cancer (MBC).
O’Donnell, Peter H. , Nurhussein-Patterson, Ashley, Huo, Dezheng , Morrow, Phuong K. , Storniolo, Anna Maria , Forero‐Torres, Andres , Poznak, Catherine Van , Merkel, Douglas E., Rosner, Gary L. , Ratain, Mark J. , Dolan, M. Eileen , Nanda, Rita , Trubetskoy, Vassily Vladimirovich , Hall, Julianne P. , Fleming, Gini F. , Ingle, James N. , Mayer, Ingrid A. , Olopade, Olufunmilayo I. , Cox, Nancy J.
Journal of Clinical Oncology | March 7, 2019 | Volume: 33 | Issue: 15_suppl | Pages: 1049-1049
Clinical evaluation of germline polymorphisms (SNPs) associated with disease response to capecitabine in metastatic breast cancer (MBC) (TBCRC 015).
Evans, Patrick , Morrow, Phuong K. , Storniolo, Anna Maria , Forero‐Torres, Andres , Poznak, Catherine Van , Merkel, Douglas E., Dees, Elizabeth Claire , Hahn, Olwen, Hoffman, Philip C., Nanda, Rita , O’Donnell, Peter H. , Choudhury, Noura J. , Ingle, James N. , Mayer, Ingrid A. , Fleming, Gini F. , Olopade, Olufunmilayo I. , Cox, Nancy J.
Journal of Clinical Oncology | September 5, 2018 | Volume: 36 | Issue: 15_suppl | Pages: 1071-1071